PL3821910T3 - Oligosacharyd i sposób jego wytwarzania - Google Patents

Oligosacharyd i sposób jego wytwarzania

Info

Publication number
PL3821910T3
PL3821910T3 PL20200455.2T PL20200455T PL3821910T3 PL 3821910 T3 PL3821910 T3 PL 3821910T3 PL 20200455 T PL20200455 T PL 20200455T PL 3821910 T3 PL3821910 T3 PL 3821910T3
Authority
PL
Poland
Prior art keywords
oligosaccharide
preparation
Prior art date
Application number
PL20200455.2T
Other languages
English (en)
Inventor
Hans Andreasen
Original Assignee
Pharmacosmos Holding A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41350678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3821910(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacosmos Holding A/S filed Critical Pharmacosmos Holding A/S
Publication of PL3821910T3 publication Critical patent/PL3821910T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Optical Recording Or Reproduction (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL20200455.2T 2009-03-25 2009-03-25 Oligosacharyd i sposób jego wytwarzania PL3821910T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20200455.2A EP3821910B1 (en) 2009-03-25 2009-03-25 An oligosaccharide and a process for preparation thereof
PCT/DK2009/050069 WO2010108493A1 (en) 2009-03-25 2009-03-25 A stable iron oligosaccharide compound

Publications (1)

Publication Number Publication Date
PL3821910T3 true PL3821910T3 (pl) 2025-06-09

Family

ID=41350678

Family Applications (3)

Application Number Title Priority Date Filing Date
PL09776213T PL2411053T3 (pl) 2009-03-25 2009-03-25 Stabilny związek żelaza i oligosacharydu
PL16201189T PL3156075T3 (pl) 2009-03-25 2009-03-25 Oligosacharyd i sposób jego wytwarzania
PL20200455.2T PL3821910T3 (pl) 2009-03-25 2009-03-25 Oligosacharyd i sposób jego wytwarzania

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL09776213T PL2411053T3 (pl) 2009-03-25 2009-03-25 Stabilny związek żelaza i oligosacharydu
PL16201189T PL3156075T3 (pl) 2009-03-25 2009-03-25 Oligosacharyd i sposób jego wytwarzania

Country Status (25)

Country Link
US (8) US8815301B2 (pl)
EP (4) EP3156075B1 (pl)
JP (1) JP5426010B2 (pl)
KR (1) KR101580348B1 (pl)
CN (3) CN108752395A (pl)
AU (1) AU2009342799B2 (pl)
BR (1) BRPI0924653B8 (pl)
CA (1) CA2756580A1 (pl)
CY (2) CY1118725T1 (pl)
DK (2) DK2411053T3 (pl)
EA (1) EA023917B1 (pl)
ES (3) ES3009818T3 (pl)
HR (3) HRP20250214T1 (pl)
HU (2) HUE030866T2 (pl)
LT (2) LT2411053T (pl)
MX (1) MX2011009936A (pl)
NZ (1) NZ595597A (pl)
PH (1) PH12015500891B1 (pl)
PL (3) PL2411053T3 (pl)
PT (2) PT3156075T (pl)
RS (2) RS61104B1 (pl)
SI (2) SI2411053T1 (pl)
UA (1) UA103373C2 (pl)
WO (1) WO2010108493A1 (pl)
ZA (1) ZA201107431B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007205167B2 (en) 2006-01-06 2013-06-13 Vifor (International) Ag Methods and compositions for administration of iron
ES3009818T3 (en) 2009-03-25 2025-04-01 Pharmacosmos Holding As An oligosaccharide and a process for preparation thereof
CN103626807B (zh) * 2013-11-20 2017-07-07 青岛国风药业股份有限公司 一种多糖铁复合物的制备方法及其质量检测方法
CZ2014451A3 (cs) * 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
RS59240B1 (sr) * 2014-10-27 2019-10-31 Pharmacosmos Holding As Lečenje ili prevencija anemije kod gravidnih sisara koji nisu ljudi i njihovih potomaka
EP3310364B1 (en) * 2015-06-22 2021-09-15 Pharmacosmos Holding A/s Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant
US10258647B2 (en) 2015-09-01 2019-04-16 Particle Dynamics International, Llc Iron-polysaccharide complexes and methods for the preparation thereof
CA2932075C (en) * 2015-09-01 2020-11-17 Particle Dynamics International, Llc Iron-polysaccharide complexes and methods for the preparation thereof
CN105908611A (zh) * 2016-06-12 2016-08-31 天津康远工程机械有限公司 具有清洗功能的自动找平双层预应力烫平板
EP3450443A1 (en) 2017-08-29 2019-03-06 Jennewein Biotechnologie GmbH Process for purifying sialylated oligosaccharides
RS66675B1 (sr) * 2017-09-11 2025-05-30 Pharmacosmos Holding As Kompleksna jedinjenja gvožđa za terapeutsku upotrebu
CN109646454A (zh) * 2018-12-29 2019-04-19 博瑞生物医药（苏州）股份有限公司 异麦芽糖酐铁1000的制备方法
US20220062331A1 (en) * 2019-01-10 2022-03-03 Pharmacosmos Holding A/S Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation
EA202191858A1 (ru) 2019-06-12 2021-11-12 Фармакосмос Холдинг А/С Лечение дефицита железа у субъектов с риском нежелательных явлений со стороны сердечно-сосудистой системы и железо для лечения фибрилляции предсердий
US11447513B2 (en) * 2020-02-12 2022-09-20 Rk Pharma Inc. Purification process of ferric carboxymaltose
JP2024529536A (ja) 2021-08-03 2024-08-06 ファーマコスモス ホールディング エー／エス コンパニオンアニマルの鉄欠乏症の治療における皮下使用のための鉄錯体化合物
WO2024069644A1 (en) * 2022-09-30 2024-04-04 West Bengal Chemical Industries Limited A pharmaceutically acceptable ferric carboxymaltose and preparation thereof
CN116726045B (zh) * 2023-06-30 2024-03-19 重庆汉佩生物科技有限公司 一种氟雷拉纳组合物
CN116672360B (zh) * 2023-06-30 2024-05-14 重庆汉佩生物科技有限公司 一种妥曲珠利与葡庚糖酐铁的组合物

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA623412A (en) 1961-07-04 Muller Arthur Iron polyisomaltose complexes for therapeutical application
CA623411A (en) 1961-07-04 Muller Arthur Process for the manufacture of iron-polyisomaltose complex for therapeutical purposes
US2807610A (en) * 1952-02-15 1957-09-24 Baker Chem Co J T Hydrogenated dextran
US3100202A (en) 1960-06-17 1963-08-06 Muller Arthur Process for preparing an iron hydroxide polyisomaltose complex and the resulting product
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
DE1293144B (de) * 1964-11-04 1969-04-24 Hausmann Ag Labor Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid
US3639588A (en) 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
GB1594697A (en) * 1977-04-19 1981-08-05 Pharmacia Ab Oligosaccharide compositions for parenteral use
DE3026868C2 (de) 1980-07-16 1986-03-13 Laboratorien Hausmann AG, St. Gallen Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung
US4518581A (en) * 1981-11-02 1985-05-21 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Imparting low- or anti-cariogenic property to orally-usable products
DE3422249A1 (de) 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
US5624668A (en) 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations
US6219440B1 (en) 1997-01-17 2001-04-17 The University Of Connecticut Method and apparatus for modeling cellular structure and function
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DK173138B1 (da) * 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
US6599498B1 (en) 1999-04-09 2003-07-29 Advanced Magnetics, Inc. Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives
KR20020096284A (ko) * 2001-06-19 2002-12-31 현대자동차주식회사 자동차의 연료 누유 진단장치
PL373403A1 (pl) * 2002-04-09 2005-08-22 Pharmacosmos Holding A/S Związki żelaza z dekstryną do leczenia niedokrwistości z niedoboru żelaza
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6960571B2 (en) 2003-03-14 2005-11-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
US20060116349A1 (en) 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
ATE445406T1 (de) * 2005-02-09 2009-10-15 Vifor Int Ag Verwendung von eisen(iii)-komplexverbindungen
ITMO20050056A1 (it) 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
CN100528237C (zh) * 2005-04-26 2009-08-19 重庆医药工业研究院有限责任公司 多核的氢氧化铁-糖复合物的制备方法
EP1757299A1 (de) 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
AU2007205167B2 (en) 2006-01-06 2013-06-13 Vifor (International) Ag Methods and compositions for administration of iron
EP1997833A1 (de) 2007-05-29 2008-12-03 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
ES3009818T3 (en) 2009-03-25 2025-04-01 Pharmacosmos Holding As An oligosaccharide and a process for preparation thereof
AU2013330387B2 (en) 2012-07-27 2017-01-19 Intrinsic Lifesciences Llc Method of treating iron deficiency anemia
US20140121193A1 (en) 2012-11-01 2014-05-01 Robert S. Katz Methods for treating fibromyalgia
JP6438887B2 (ja) 2012-11-30 2018-12-19 ファーマコスモス・アクティーゼルスカブＰｈａｒｍａｃｏｓｍｏｓ Ａ／Ｓ 凍結防止剤、凍結防止および凍結保存組成物、その使用ならびに凍結保存方法

Also Published As

Publication number Publication date
US10865255B2 (en) 2020-12-15
JP5426010B2 (ja) 2014-02-26
PH12015500891A1 (en) 2016-11-14
RS61104B1 (sr) 2020-12-31
KR20120016063A (ko) 2012-02-22
UA103373C2 (ru) 2013-10-10
US11851504B2 (en) 2023-12-26
ES2840074T3 (es) 2021-07-06
EP3821910B1 (en) 2024-12-25
EP4545137A3 (en) 2025-07-09
PT2411053T (pt) 2017-02-15
EP3821910A1 (en) 2021-05-19
CY1123651T1 (el) 2022-03-24
EP2411053A1 (en) 2012-02-01
US20210108004A1 (en) 2021-04-15
US20140364598A1 (en) 2014-12-11
HRP20201903T1 (hr) 2021-01-22
US20250026864A1 (en) 2025-01-23
LT2411053T (lt) 2017-04-10
BRPI0924653B1 (pt) 2019-10-08
CN102361651A (zh) 2012-02-22
US20190135947A1 (en) 2019-05-09
SI3156075T1 (sl) 2021-03-31
ES3009818T3 (en) 2025-04-01
US10414831B2 (en) 2019-09-17
EP4545137A2 (en) 2025-04-30
PL2411053T3 (pl) 2017-06-30
EA201190214A1 (ru) 2012-04-30
HUE052617T2 (hu) 2021-05-28
ES2617658T3 (es) 2017-06-19
US9439969B2 (en) 2016-09-13
LT3156075T (lt) 2021-01-11
US12030962B2 (en) 2024-07-09
EA023917B1 (ru) 2016-07-29
BRPI0924653B8 (pt) 2021-05-25
CA2756580A1 (en) 2010-09-30
US20210130505A1 (en) 2021-05-06
EP2411053B1 (en) 2016-11-30
AU2009342799B2 (en) 2014-12-18
DK3156075T3 (da) 2020-11-30
WO2010108493A1 (en) 2010-09-30
JP2012521369A (ja) 2012-09-13
HRP20250214T1 (hr) 2025-04-25
EP3156075B1 (en) 2020-10-14
MX2011009936A (es) 2011-10-06
SI2411053T1 (sl) 2017-04-26
PT3156075T (pt) 2021-01-05
HRP20170230T1 (hr) 2017-04-07
HK1164138A1 (en) 2012-09-21
EP3156075A1 (en) 2017-04-19
HUE030866T2 (en) 2017-06-28
US8815301B2 (en) 2014-08-26
AU2009342799A1 (en) 2011-11-03
US20140303364A1 (en) 2014-10-09
RS55700B1 (sr) 2017-07-31
US20160333118A1 (en) 2016-11-17
EP3821910C0 (en) 2024-12-25
US20120010166A1 (en) 2012-01-12
PL3156075T3 (pl) 2021-04-19
ZA201107431B (en) 2012-07-25
KR101580348B1 (ko) 2016-01-04
BRPI0924653A2 (pt) 2016-01-26
CN108752395A (zh) 2018-11-06
DK2411053T3 (en) 2017-02-20
PH12015500891B1 (en) 2020-02-05
CY1118725T1 (el) 2017-07-12
NZ595597A (en) 2013-05-31
CN109700828A (zh) 2019-05-03

Similar Documents

Publication Publication Date Title
PL3821910T3 (pl) Oligosacharyd i sposób jego wytwarzania
IL216305A0 (en) Solid forms and process for preparing
GB0918069D0 (en) Process
GB0919117D0 (en) Process
GB0901254D0 (en) Process
GB0919385D0 (en) Process
GB0907879D0 (en) Process
GB0912255D0 (en) Process
GB0905331D0 (en) Expression process
GB0918830D0 (en) Process
GB0905998D0 (en) Process
GB0906191D0 (en) Process
GB2468856B (en) A process
GB0914500D0 (en) Process
GB0901817D0 (en) Process
ZA201109439B (en) Process for preparing alkylalkanolamines
GB0901816D0 (en) Process
GB0914572D0 (en) Process
GB0902286D0 (en) Process
GB2468855B (en) A process
GB0915106D0 (en) Process
GB0913318D0 (en) Process
GB0907942D0 (en) Process
PL2504631T3 (pl) Element łączący i sposób jego wytwarzania
GB0906031D0 (en) Process